重點成果

重點成果

• 
  2025-06-20 重點成果

  Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold

  陳建仁, 楊懷壹
  GUT

• 
  2025-06-11 重點成果

  Membrane Disruption Properties of Poly-Glycine Arginine Dipeptide Repeats Affected by Peptide Repeats Continuity and Membrane Composition

  陳韻如
  Journal of Molecular Biology

• 
  2025-03-28 重點成果

  RRM1 O-GlcNAcylation inhibition suppresses pancreatic cancer via TK1-mediated replication stress.

  胡春美
  Cancer Gene Therapy

• 
  2025-03-25 重點成果

  Higher level of HBsAg associated with delayed development of HCC in immune-tolerant patients

  陳建仁, 楊懷壹
  Hepatology

• 
  2025-02-28 重點成果

  Tau destabilization in a familial deletion mutant K280 accelerates its fibrillization and enhances the seeding effect

  陳韻如
  Journal of Biological Chemistry

• 
  2025-02-05 重點成果

  Innovative cyclic peptide disrupts IL-17RB–MLK4 interaction for targeted pancreatic cancer therapy

  胡春美
  Biomedicine & Pharmacotherapy

• 
  2024-12-17 重點成果

  Tacrolimus regulates extracellular vesicle secretion from T cells via autophagy-lysosomal pathway

  胡春美
  Biomedicine & Pharmacotherapy

• 
  2024-10-30 重點成果

  Glycoengineering for a Universal COVID-19 Vaccine

  翁啟惠
  Scientia

• 
  2024-10-24 重點成果

  SEMA7A-mediated juxtacrine stimulation of IGFBP-3 upregulates IL-17RB at pancreatic cancer invasive front

  胡春美
  Cancer Gene Therapy

• 
  2024-10-17 重點成果

  Reverse hierarchical DED assembly in the cFLIP-procaspase-8 and cFLIP-procaspase-8-FADD complexes

  林世昌
  Nature Communications